Liraglutide
NDC 70377-095, liraglutide, injection, solution, from Biocon Pharma Inc..
- Product NDC
- 70377-095
- Status
- Listed
- Labeler
- Biocon Pharma Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217063
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70377-095 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LIRAGLUTIDE6 mg/mL
Pharmacologic classes
GLP-1 Receptor Agonist [EPC]; Glucagon-Like Peptide 1 [CS]; Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70377-095-52 | 70377009552 | 3 SYRINGE, PLASTIC in 1 CARTON (70377-095-52) / 3 mL in 1 SYRINGE, PLASTIC |
| 70377-095-53 | 70377009553 | 5 SYRINGE, PLASTIC in 1 CARTON (70377-095-53) / 3 mL in 1 SYRINGE, PLASTIC |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/0b898330-eca1-f60a-71d2-b91716e336edNADAC price for package 70377009553
GET /v1/drugs/nadac/70377009553
Use it
Look up 70377-095 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70377-095 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70377-095. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.